Serum proteomics as a strategy to identify novel biomarkers of neurologic recovery after cardiac arrest: a feasibility study

Intensive Care Medicine Experimental

Table 1 Patient demographics and clinical characteristics

Patient #	Age/gender	Comorbidities	Rhythm	CPC
Good neurological outcome
1	61 M	Obesity/OA	VF	1
2	76 F	Obesity, HTN, DM, AS, AF	PEA*	1
3	62 M	COPD, CKD, CAD, DM, CHF	VT	1
7	46 M	Healthy	VF	1
9	37 F	Endometriosis, nephrolithiasis, epilepsy	VT	1
10	57 M	Healthy	VF	1
Poor neurological outcome
4	68 M	HTN, DM, smoker	VF	4
5	70 M	Healthy	VF	5
6	47 M	Healthy	VF	5
8	67 M	HTN, AF	VF	5
11	27 M	Healthy	VF/VT	5

The demographic information, initial rhythm, and 3-month neurological outcome are shown for the 11 patients recruited into the study
CPC cerebral performance category, VF ventricular fibrillation, OA osteoarthritis, HTN hypertension, DM diabetes mellitus, AS aortic stenosis, AF atrial fibrillation, COPD chronic obstructive pulmonary disease, CKD chronic kidney disease, CAD coronary artery disease, CHF congestive heart failure, PEA pulseless electrical activity, VT ventricular tachycardia.
* Patient was initially classified as having VF, but reclassified later as having a non-perfusing bradycardia (see text for details)